HubSpot Faces Bumpy AI Pricing Transition
- •HubSpot says outcome-based AI agent pricing is lengthening sales cycles as customers seek proof of value
- •Agent trials grew 64% sequentially in Q3, while customers sought hands-on support to achieve outcomes
- •HubSpot forecast Q4 revenue of $945 million to $947 million, below analysts’ $965 million estimate
HubSpot said its shift to outcome-based pricing for AI agents is extending sales cycles and weighing on near-term results, as customers demand proof of value and smaller businesses scrutinize budgets. CEO Yamini Rangan described the pressures on the company’s third-quarter earnings call, saying headwinds seen in Q2 continued and became more pronounced in Q3. HubSpot introduced free trials and value- and outcome-based pricing in Q2, expecting longer buying cycles as customers assess whether AI works with their own data and systems.
Agent trials grew 64% sequentially in Q3, Rangan said, but customers need hands-on support to turn trials into outcomes. HubSpot is using partners and consultants to provide that help. The company also reported pressure on inbound demand and is diversifying through intent-based marketing, LLM connectors and AEO. Rangan said larger customers are involving more executives and board members in purchases, while smaller customers are more price-sensitive and focused on cost optimization. HubSpot is adjusting its sales approach; Rangan said consumption revenue and headless options would benefit the company over time.
HubSpot’s Q3 results exceeded expectations, but its Q4 forecast fell short. Net income was $83 million, or $1.67 a share, on revenue of $947.6 million, up 17% year over year. Non-GAAP earnings were $3.81 a share, 54 cents above estimates. For Q4, HubSpot forecast revenue of $945 million to $947 million, up 12% year over year, and non-GAAP earnings of $3.85 to $3.87 a share. Analysts expected $965 million in revenue and $4.09 a share in non-GAAP earnings. For 2026, the company projected revenue of $3.685 billion to $3.687 billion, up about 18% from the previous year, and non-GAAP earnings of $13.59 to $13.61 a share; that full-year outlook was above estimates.